| Literature DB >> 32333879 |
Dominic Ehrmann1, Bernhard Kulzer2, Timm Roos3, Thomas Haak4, Mohammed Al-Khatib5, Norbert Hermanns6.
Abstract
Diabetic ketoacidosis (DKA) is a serious acute complication of type 1 diabetes, which is receiving more attention given the increased DKA risk associated with SGLT inhibitors. Sociodemographic and modifiable risk factors were identified with strong evidence for an increased risk of DKA, including socioeconomic disadvantage, adolescent age (13-25 years), female sex, high HbA1c, previous DKA, and psychiatric comorbidities (eg, eating disorders and depression). Possible prevention strategies, which include the identification of people at risk based on non-modifiable sociodemographic risk factors, are proposed. As a second risk mitigation strategy, structured diabetes self-management education that addresses modifiable risk factors can be used. Evidence has found that structured education leads to reduced DKA rates. Knowledge of these risk factors and potent risk mitigation strategies are important to identify subgroups of people with an elevated DKA risk. This knowledge should also be used when adjunct therapy options with an increased DKA risk are considered. Prevention of DKA in people with type 1 diabetes is an important clinical task, which should also be addressed when SGLT inhibitors are part of therapy.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32333879 DOI: 10.1016/S2213-8587(20)30042-5
Source DB: PubMed Journal: Lancet Diabetes Endocrinol ISSN: 2213-8587 Impact factor: 32.069